| 注册
首页|期刊导航|中国药理学通报|CCL2/MCP-1在其相关疾病的机制研究

CCL2/MCP-1在其相关疾病的机制研究

姜懿纳 陈乃宏

中国药理学通报2016,Vol.32Issue(12):1634-1638,5.
中国药理学通报2016,Vol.32Issue(12):1634-1638,5.DOI:10.3969/j.issn.1001-1978.2016.12.002

CCL2/MCP-1在其相关疾病的机制研究

Mechanism of CCL2/MCP-1 in its relevant diseases

姜懿纳 1陈乃宏2

作者信息

  • 1. 湖南中医药大学药学院,湖南 长沙 410208
  • 2. 中国医学科学院北京协和医学院药物研究所,北京 100050
  • 折叠

摘要

Abstract

Chemokine is a small protein which plays an impor-tant role in men's physiological function.It has chemotactic ac-tivity and is often secreted by immune cells and glial cells like microglia or astrocytes.Through the effect of chemokine recep-tors on target cells,various immune cells can achieve directional migration and play an important role in the diseases related with immunity and inflammation.CCL2,also known as monocyte chemotactic protein-1 (MCP-1 ),is one member of chemokine CC subfamily (βsubfamily).It can chemokine monocytes, macrophages and T lymphocytes to affect their phagocytosis func-tion and produce antibodies to combat invading microorganisms. In recent years,it has been found that CCL2 plays a key role in the occurrence and development of the problems concerning cen-tral nervous system and immune system as well as cancer, AIDS,leukemia,diabetes and other diseases.This thesis is to give an elaboration on the latest research on CCL2 and the rele-vant diseases.

关键词

趋化因子/CCL2/受体/单核细胞/免疫系统/肿瘤/神经疾病

Key words

chemokines/CCL2/receptor/monocytes/immu-nity system/cancer/nerve disease

引用本文复制引用

姜懿纳,陈乃宏..CCL2/MCP-1在其相关疾病的机制研究[J].中国药理学通报,2016,32(12):1634-1638,5.

基金项目

国家自然科学基金资助项目(No 81373997);北京市自然科学基金资助项目 ()

中国药理学通报

OA北大核心CSCDCSTPCD

1001-1978

访问量0
|
下载量0
段落导航相关论文